ĀÜĄņĀŅĀ×

Laura A. Coruzzi is the Executive Vice President of Intellectual Property at REGENXBIO. Prior to joining REGENXBIO, Ms. Coruzzi was a partner at Jones Day, preceded by Pennie & Edmonds, LLP where she counseled clients on patent strategies for biotech and pharmaceutical therapeutics and diagnostics. Her practice encompassed all aspects of patent law, including prosecution, litigation and appeals, in a variety of disciplines in the life sciences, including genetic engineering, molecular biology, virology, vaccines, immunology, therapeutic antibodies, other biologic and small molecule therapeutics, diagnostics, drug discovery, and drug delivery.

Earlier in her career, Ms. Coruzzi was one of the first members of Pennie & Edmondsā€™ biotechnology group founded by S. Leslie Misrock, affectionately known as the "father of biotechnology patent law.ā€ Most recently, she was a member of the team representing Myriad in Association for Molecular Pathology v. Myriad Genetics (U.S. Supreme Court 2013).

Ms. Coruzzi received her J.D. from Fordham University School of Law, her Ph.D., M.S. and B.S. in Biology from Fordham University, and completed a post-doctoral fellowship at the Mount Sinai School of Medicine before entering the practice of law.